Early-onset Alzheimer Disease and Its Variants.
Mendez MF.
Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA.
Science. 1993 Aug 13;261(5123):921-3. doi: 10.1126/science.8346443.
Risk factors for Alzheimer's disease.
A Armstrong R.
Folia Neuropathol. 2019;57(2):87-105. doi: 10.5114/fn.2019.85929.
Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY, Zhang Y.
Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289.
An overview of the genes and biomarkers in Alzheimer's disease.
Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, Rajasekaran JJ.
Ageing Res Rev. 2025 Feb;104:102599. doi: 10.1016/j.arr.2024.102599. Epub 2024 Nov 28.
Genetics of familial and sporadic Alzheimer's disease.
Piaceri I, Nacmias B, Sorbi S.
Front Biosci (Elite Ed). 2013 Jan 1;5(1):167-77. doi: 10.2741/e605.
TREM2 - a key player in microglial biology and Alzheimer disease.
Ulland TK, Colonna M.
Nat Rev Neurol. 2018 Nov;14(11):667-675. doi: 10.1038/s41582-018-0072-1.
Cannabinoids in late-onset Alzheimer's disease.
Ahmed A, van der Marck MA, van den Elsen G, Olde Rikkert M.
Clin Pharmacol Ther. 2015 Jun;97(6):597-606. doi: 10.1002/cpt.117. Epub 2015 Apr 17.
The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease.
Hogan R, Flamier A, Nardini E, Bernier G.
Genes (Basel). 2020 Jul 21;11(7):825. doi: 10.3390/genes11070825.
Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease.
Rubino E, Italia M, Giorgio E, Boschi S, Dimartino P, Pippucci T, Roveta F, Cambria CM, Elia G, Marcinnò A, Gallone S, Rogaeva E, Antonucci F, Brusco A, Gardoni F, Rainero I.
Alzheimers Res Ther. 2025 Jan 14;17(1):21. doi: 10.1186/s13195-024-01661-y.
